Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001178937-25-000021
Filing Date
2025-05-20
Accepted
2025-05-20 18:19:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2743
  Complete submission text file 0001178937-25-000021.txt   4529
Mailing Address 888 BOYLSTON, SUITE 500 BOSTON MA 02199
Business Address 888 BOYLSTON, SUITE 500 BOSTON MA 02199 (617) 449-7700
M33 Growth I L.P. (Reporting) CIK: 0001718621 (see all company filings)

EIN.: 822962623 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Subject) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39248 | Film No.: 25970395
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)